Antimicrobial and non-antimicrobial tetracyclines in human cancer trials

Pharmacological Research

Volumn 63, Issue 2, 2011, Pages 151-156

  Richards, Christopher ^a   Pantanowitz, Liron ^b   Dezube, Bruce J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

CMT 3; COL 3; Kaposi Sarcoma; Matrix metalloproteinases; Metastat; Tetracyclines

Indexed keywords

4 DEDIMETHYLAMINO TETRACYCLINE; ALPHA INTERFERON; ANTIBIOTIC AGENT; COLLAGENASE; DOXYCYCLINE; GELATINASE A; GELATINASE B; INCYCLINIDE; MARIMASTAT; MATRIX METALLOPROTEINASE; TANOMASTAT; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANEMIA; ANTIMICROBIAL ACTIVITY; ARTICLE; CANCER SURVIVAL; CANCER THERAPY; CONSTIPATION; DIZZINESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EYE CANCER; FATIGUE; FEVER; GASTROINTESTINAL SYMPTOM; GLIOBLASTOMA; HEADACHE; HUMAN; KAPOSI SARCOMA; KIDNEY CARCINOMA; LEUKOPENIA; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; LUPUS LIKE SYNDROME; LYMPHOMA; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROTOXICITY; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PHOTOTOXICITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN TARGETING; SIDE EFFECT; SIDEROBLASTIC ANEMIA; SOFT TISSUE SARCOMA; SOLID TUMOR; STOMACH CANCER; THROMBOCYTOPENIA; TUMOR VASCULARIZATION; TUMOR VOLUME; UTERUS CANCER; VOMITING; WEIGHT REDUCTION;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASMS; PERIODONTAL DISEASES; SARCOMA, KAPOSI; TETRACYCLINES;

EID: 79251612333     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.10.008     Document Type: Article

References (50)

1. E.C. Woodhouse, R.F. Chuaqui, and L.A. Liotta General mechanisms of metastasis Cancer 80 1997 1529 1537
2. J. Arribas Matrix metalloproteinases and tumor invasion NEJM 352 2005 2020 2021
3. R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 2005 58 62
4. T.G. Wolfsberg, P. Primakoff, D.G. Myles, and J.M. White ADAM, a novel family of membrane proteins containing A Disintegrin and metalloproteinases domain: multipotential functions in cell-cell and cell-matrix interactions J Cell Biol 131 1995 275 278
5. M.L. Moss, and M.H. Lambert Shedding of membrane proteins by ADAM family proteases Essays Biochem 38 2002 141 153
6. J.C. Clark, D.M. Thomas, P.F. Choong, and C.R. Dass RECK - a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer Cancer Metastasis Rev 26 2007 675 683
7. C.F. Chantrain, H. Shimada, S. Jodele, S. Groshen, W. Ye, and D.R. Shalinsky Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment Cancer Res 64 2004 1675 1686
8. B. Fingleton Matrix metalloproteinases: roles in cancer and metastasis Front Biosci 11 2006 479 491
9. V. Masson, L.R. de la Ballina, C. Munaut, B. Wielockx, M. Jost, and C. Mallard Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes FASEB J 19 2005 234 236
10. B.P. Himelstein, and C.J. Koch Studies of type IV collagenase regulation by hypoxia Cancer Lett 124 1998 127 133
11. N. Masumori, T. Tsukamoto, N. Miyao, Y. Kumamoto, I. Saiki, and J. Yoneda Inhibitory effect of Minocycline on in vitro invasion and experimental metastasis of mouse renal adenocarcinoma J Urol 151 1994 1400 1404
12. T. Itoh, M. Tanioka, H. Yoshida, T. Yoshioka, H. Nishimoto, and S. Itohara Reduced angiogenesis and tumor progression in gelatinase A-deficient mice Cancer Res 58 1998 1048 1051
13. M.A. Moses, D. Weiderschain, K.R. Loughlin, D. Zurakowski, C.C. Lamb, and M.R. Freeman Increased incidence of matrix metalloproteinase's in urine of cancer patients Cancer Res 58 1998 1395 1399
14. R. Roy, J. Yang, and M. Moses Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer J Clin Oncol 27 2009 5287 5297
15. M. Hidalgo, and S.G. Eckhardt Development of matrix metalloproteinase inhibitors in cancer therapy J Natl Cancer Inst 93 2001 178 193
16. N.G. Lia, Z.H. Shib, Y.P. Tang, and J.A. Duan Selective matrix metalloproteinase inhibitors for cancer Curr Med Chem 16 2009 3805 3827
17. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2002 2387 2392
18. W.T. Purcell, M.A. Rudek, and M. Hidalgo Development of matrix metalloproteinase inhibitors in cancer therapy Hematol Oncol Clin N Am 16 2002 1189 1227 (Pubitemid 35462920)
19. L.M. Golub, H.M. Lee, G. Lehrer, A. Nemiroff, T.F. McNamara, and R. Kaplan Minocycline reduces gingival collagnolytic activity during diabetes J Perid Res 18 1983 516 526
20. J.V. Ghate, M.L. Turner, M.A. Rudek, W.D. Figg, W. Dahut, and V. Dyer Drug-induced lupus associated with COL-3: report of 3 cases Arch Dermatol 137 2001 471 474
21. L.M. Golub, T.F. McNamara, G. D'Angelo, R.A. Greenwald, and N.S. Ramamurthy A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity J Dent Res 66 1987 1310 1314
22. B.L. Lokeshwar, E. Escatel, and B. Zhu Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3) Curr Med Chem 8 2001 271 279
23. L.M. Golub, R.A. Greenwald, N.S. Ramamurthy, T.F. McNamara, and B.R. Rifkin Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs Crit Rev Oral Biol Med 2 1991 297 322
24. Y. Gu, H.M. Lee, E.J. Roemer, L. Musacchia, L.M. Golub, and S.R. Simon Inhibition of tumor cell invasiveness by chemically modified tetracyclines Curr Med Chem 8 2001 261 270
25. R.N. Patel, M.G. Attur, M.N. Dave, I.V. Patel, S.A. Stuchin, and S.B. Abramson A novel mechanism of action of chemically modified tetracyclines: inhibition of COX-2 mediated prostaglandin E2 production J Immunol 163 1999 3459 3467
26. B.L. Lokeshwar, M.G. Selzer, B.Q. Zhu, N.L. Block, and L.M. Golub Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model Int J Cancer 98 2002 297 309
27. Z. Saikali, and G. Singh Doxycycline and other tetracyclines in the treatment of bone metastasis Anti-Cancer Drugs 14 2003 773 778
28. C. Van den Bogert, B.H. Dontje, M. Holtrop, T.E. Melis, J.C. Romijn, and J.W. van Dongen Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis Cancer Res 46 1986 3283 3289 (Pubitemid 16096857)
29. M.A. Rudek, W.D. Figg, V. Dyer, W. Dahut, M.L. Turner, and S.M. Steinberg I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer J Clin Oncol 19 2001 584 592
30. M.A. Rudek, W.D. Figg, V. Dyer, W. Dahut, M.L. Turner, and S.M. Steinberg Reversible sideroblastic anemia associated with the tetracycline analogue COL-3 Am J Hematol 67 2001 51 53
31. S. Syed, C. Takimoto, M. Hidalgo, J. Rizzo, J.G. Kuhn, and L.A. Hammond A phase I and pharmacokinetic study of COL-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties Clin Cancer Res 10 2004 6512 6521
32. N. Crum-Cianfone, K. Huppler Husiek, E. Satter, V. Marconi, A. Weintrob, and A. Ganesan Cutaneous malignancies among HIV-infected persons Arch Inern Med 169 2009 1130 1138
33. K. Antman, and Y. Chang Kaposi's sarcoma NEJM 342 2000 1027 1038
34. L. Pantanowitz, B.J. Dezube, S. Hernandez-Barrantes, S.R. Tahan, and M.K. Dabbous Matrix metalloproteinase's in the progression and regression of Kaposi's sarcoma J Cutan Pathol 33 2006 793 798
35. M. Cianfrocca, T.P. Cooley, J.Y. Lee, M.A. Rudek, D.T. Scadden, and L. Ratner Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study J Clin Oncol 20 2002 153 159
36. B.J. Dezube, S.E. Krown, J.Y. Lee, K.S. Bauer, and D.M. Aboulafia Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS malignancy consortium study J Clin Oncol 24 2006 1389 1393
37. M. Huie, K. Oettel, L. Van Ummersen, K.M. Kim, Y. Zhang, and M.J. Staab Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma Invest New Drugs 24 2006 255 260
38. W.H. Chow, S.S. Devesa, J.L. Warren, and J.F. Fraumeni Rising incidence of renal cell cancer in the United States JAMA 281 1999 1628
39. B. Escudier, F. Farace, E. Angevin, F. Triebel, S. Antoun, and B. Leclercq Combination of interleukin-2 and gamma interferon in metastatic renal cell carcinoma Eur J Cancer 29 1993 724 728
40. R.C. Kane, A.T. Farrel, H. Saber, S. Tang, G. Williams, and J.M. Jee Sorafenib for the treatment of advanced renal cell carcinoma Clin Cancer Res 12 2006 7271 7278
41. Q.S.C. Chu, B. Forouzesh, S. Syed, M. Mita, G. Schwartz, and J. Copper A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas Invest New Drugs 25 2007 359 367
42. M. von Mehren New therapeutic strategies for soft tissue sarcomas Curr Treat Options Oncol 4 2003 441 451
43. A.J.M. Ferreri, M. Ponzoni, M. Guidoboni, C. De Conciliis, A.G. Resti, and B. Mazzi Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy J Clin Oncol 23 2005 5067 5073
44. A.C. Wotherspoon, C. Ortiz-Hidalgo, M.R. Falzon, and P.G. Isaacson Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma Lancet 338 1991 1175 1176
45. A.J.M. Ferreri, M. Ponzoni, M. Guidoboni, A.G. Resti, L.S. Politi, and S. Cortelazzo Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial J Natl Cancer Inst 98 2006 1375 1382 (Pubitemid 44530714)
46. S. Williams, A. Wakisaka, Q.Q. Zeng, J. Barnes, G. Martin, and W.J. Wechter Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats Bone 19 1996 637 644
47. W.C. Duivenvoorden, S.V. Popovic, S. Lhotak, E. Seidlitz, H.W. Hirte, and R.G. Tozer Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer Cancer Res 62 2002 1588 1591
48. S. Okuyama, H. Mishina, A. Yoshizumi, Y. Usuba, and M. Takahasi Intratumoral doxycycline for skin metastases of human malignancies Tohoku J Exp Med 151 1987 241 244
49. M.A. Moses, J. Harper, and J. Folkman Doxycycline treatment for Lymphangioleiomyomatosis with urinary monitoring for MMPs NEJM 354 2006 2621 2622
50. D.W. Hohman, D. Noghrehkar, and S. Ratnayake Lymphangioleiomatosis: a review Eur J Intern Med 19 2008 319 324